Skip to main content
SpringerLink
Log in

Adverse Effects of Antihypertensive Drugs

  • Review Article
  • Published:
Drugs Aims and scope Submit manuscript

Summary

Early essential hypertension is asymptomatic and should remain so throughout treatment. In view of the increasing number of available antihypertensive agents, clinicians need to become familiar with the potential side effects of these drugs. By placing more emphasis on non-pharmacological treatment (sodium restriction, weight loss, exercise) and thoroughly evaluating each case in particular, the pharmacological regimen can be optimally tailored to the patient’s needs. Potential side effects should be predicted and can often be avoided; if they become clinically significant they should be rapidly recognised and corrected. These side effects can be easily remembered in most instances, as they fall into 3 broad categories: (a) those caused by an exaggerated therapeutic effect; (b) those due to a non-therapeutic pharmacological effect; and (c) those caused by a non-therapeutic, non-pharmacological effect probably representing idiosyncratic reactions. This review focuses mainly on adverse effects of the second and third kind. Each group of drugs in general shares the common side effects of the first two categories, while each individual drug has its own idiosyncratic side effects.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Adler, S.: Methyldopa induced decreased mental activity. Journal of the American Medical Association 230: 1428–1429 (1974).

    PubMed  CAS  Google Scholar 

  • Antman, E.; Muller, J.; Goldberg, S.; MacAlpin, R.; Rubenfire, M.; Tabatznik, B; Leang, C.S.; Heupler, E.; Achuff, S.; Reichek, N.; Geltman, E.; Kerin, N.Z. and Braunwold, E.: Nifedipine therapy for coronary-artery spasm. New England Journal of Medicine 302: 1262–1273(1980).

    Google Scholar 

  • Arensberg, D. and Venger, M.K.: Psychosis a probable result of propranolol therapy. International Journal of Addictions 14: 785–787 (1979).

    CAS  Google Scholar 

  • Aronow, W.S.; Lurie, M.; Turbow, M.; Whittaker, K.; Van Camp, S. and Hughes, D.: Effect of prazosin vs placebo in left ventricular heart failure. Circulation 59: 344–350 (1979).

    PubMed  CAS  Google Scholar 

  • Atkinson, A.B. and Robertson, J.I.S.: Captopril in the treatment of clinical hypertension and cardiac failure. Lancet 2: 836–839 (1979).

    PubMed  CAS  Google Scholar 

  • Bailey, R.R.; Lynn, K.L.; Neale, T.L. and Little, P.J.: Prazosin in the treatment of patients with hypertension and renal functional impairment. New Zealand Medical Journal 84: 467–468 (1976).

    PubMed  CAS  Google Scholar 

  • Barnett, D.B.; Hudson, S.A. and Golightly, P.W.: Hydralazine induced hepatitis? British Medical Journal 1: 1165–1166 (1980).

    Google Scholar 

  • Bartorelli, C; Magrini, F.; Moruzzi, P.; Olivari, M.T.; Polese, A.; Fiorentini, C. and Guazzi, M.: Haemodynamic effects of a calcium antagonistic agent (nifedipine) in hypertension: Therapeutic implications. Clinical Science and Molecular Medicine 55: 291s–292s (1979).

    Google Scholar 

  • Battock, DJ..; Alvarez, H. and Chidsey, CA.. Effects of propranolol on exercise performance and adrenergic activity in angina. Circulation 37, 38 (Suppl. 6): 39 (1968).

    Google Scholar 

  • Bauernfeind, R.; Hall, C; Henes, P. and Rosen, K.M.: Carotid sinus hypersensitivity with alpha methyldopa. Annals of Internal Medicine 82: 214–215 (1978).

    Google Scholar 

  • Bear, R. and Steer, K.: Pseudo-obstruction due to clonidine. British Medical Journal 1: 197 (1976).

    PubMed  CAS  Google Scholar 

  • Bennett, W.M.: Pericardial effusion associated with minoxidil (corresp.). Lancet 2: 1356 (1977).

    PubMed  CAS  Google Scholar 

  • Benson, M.K.; Berrill, W.T.; Sterling, G.M., Decalmer, P.B.; Chatterjee, S.S.; Croxson, R.S. and Cruickshank, J.M.: Cardioselective and non-cardioselective beta-blockers in reversible obstructive airways disease. Postgraduate Medical Journal 53 (Suppl. 3): 142–148 (1977).

    Google Scholar 

  • Bhalla, A.K.; Hoffbrand, B.I.; Phatak, P.S. and Reuben, S.R.: Prazosin and priapism. British Medical Journal 2: 1039 (1979).

    PubMed  CAS  Google Scholar 

  • Bloomfield, D.K. and Cangiano, G.L.: Clinical experience with a new antihypertensive agent guanadrel sulfate. Current Therapeutic Research 11: 727 (1969).

    PubMed  CAS  Google Scholar 

  • Blum, I.; Atsmon, A. and Steiner, M.: Paradoxical rise in blood pressure during propranolol treatment. British Medical Journal 1: 623 (1975).

    Google Scholar 

  • Bonkowsky, H. and Brisbane, J.: Colitis and hepatitis caused by methyldopa. Journal of the American Medical Association 236: 1602–1603 (1976).

    PubMed  CAS  Google Scholar 

  • Bower, P.J. and Peterson, J.N.: Methoglobinemia after sodium nitroprusside therapy. New England Journal of Medicine 293: 865 (1975).

    PubMed  CAS  Google Scholar 

  • Boyer, J.L. and Kasch, F.W.: Exercise therapy in hypertensive men. Journal -of the American Medical Association 211: 1668–1671 (1970).

    PubMed  CAS  Google Scholar 

  • Breckenridge, A.; Dollery, CT.; Worlledge, S.M.; Holborow, E.J. and Johnson, G.D.: Positive direct Coombs test and anti-nuclear factors in patients treated with methyldopa. Lancet 2: 1265–1267 (1967).

    PubMed  CAS  Google Scholar 

  • Briggs, R.S.; Birtwell, A.J. and Pohl, J.E.: Hypertensive response to labetalol in phaeochromocytoma (corresp.). Lancet 1: 1045–1046 (1978).

    PubMed  CAS  Google Scholar 

  • Brogden, R.N.; Heel, R.C.; Speight, T.M. and Avery, G.S.: Prazosin: A review of its pharmacological properties and therapeutic efficacy in hypertension. Drugs 14: 163–197 (1977).

    PubMed  CAS  Google Scholar 

  • Brown, M.J.; Salmon, D. and Rendeu, M.: Clonidine hallucinations. Annals of Internal Medicine 91: 456–457 (1980)

    Google Scholar 

  • Bullock, J.D.: Antihypertensive drugs and danger to vision (corresp.) Journal of the American Medical Association 37: 2186 (1977).

    Google Scholar 

  • Burdin, A.C. and Alexander, C.P.: Rebound hypertension to acute methyldopa withdrawal. British Medical Journal 1: 1056 (1976).

    Google Scholar 

  • Canady, B.: Minoxidil. Southern Medical Journal 73: 59–64 (1980).

    Google Scholar 

  • Case, D.B., Atlas, S.A.; Mouradian, J.A. and Fishman, R.A.: Proteinuria during long-term captopril therapy. Journal of the American Medical Association 244: 346–349 (1980).

    PubMed  CAS  Google Scholar 

  • Charles, M.A. and Danforth, E. Jr; Nonketoacidotic hyperglycemia and coma during intravenous diazoxide therapy in uremia. Diabetes 20: 501–503 (1971).

    PubMed  CAS  Google Scholar 

  • Charness, M.E.; Fishman, J.A. and Robertson, D.: Exacerbation of angina pectoris by prazosin. Southern Medical Journal 72: 1213–1214 (1979).

    PubMed  CAS  Google Scholar 

  • Chrysant, S.G. and Fröhlich, E.D.: Side-effects of antihypertensive drugs. American Family Physician 9: 99 (1974).

    Google Scholar 

  • Chrysant, S.G. and Fröhlich, E.D.: Comparison of the antihypertensive effectiveness of guanadrel and guanethidine. Current Therapeutic Research 19: 276 (1976).

    Google Scholar 

  • Conn, J.N. and Franciosa, J.A.: Vasodilator therapy of cardiac failure. New England Journal of Medicine 297: 254–258 (1977).

    Google Scholar 

  • Cokkinos, D.V. and Vorides, E.M.: Impairment of atrioventricular conduction by methyldopa (corresp.). Chest 74: 697 (1978).

    PubMed  CAS  Google Scholar 

  • Collins, I.S. and King, I.W.: Pindolol (Viskin LB46): A new treatment for hypertension: Report of a multicentric open study. Current Therapeutic Research 14: 185–194(1972).

    PubMed  CAS  Google Scholar 

  • Cottrell, J.; Casthely, P.; Brodie, J.D.; Patel, K.; Klein, A. and Turndorf, H.: Prevention of nitroprusside-induced cyanide toxicity with hydroxocobalamin. New England Journal of Medicine 298: 809–811 (1978).

    PubMed  CAS  Google Scholar 

  • Cove, D.H.; Seddon, M.; Fletcher, R.F. and Dukes, D.C.: Blindness after treatment for malignant hypertension. British Medical Journal 2: 245–246 (1979).

    PubMed  CAS  Google Scholar 

  • Crofton, M. and Gabriel, R.: Pressor response after intravenous labetalol. British Medical Journal 2: 737 (1977).

    PubMed  CAS  Google Scholar 

  • Crossman, A.: Captopril and reversible renal failure. Lancet 1: 712(1980).

    Google Scholar 

  • Crossman, A.; Eckland, D.; Price, P. and Edwards, C.R.W.: Fatal hepatotoxicity in a child on phenobarbitone and sodium valproate. Lancet 1: 712 (1980).

    Google Scholar 

  • Dale, R.C. and Schroeder, E.T.: Respiratory paralysis during treatment of hypertension with trimethaphan camsylate. Archives of Internal Medicine 136: 816–818 (1976).

    PubMed  CAS  Google Scholar 

  • DeBard, M.L.: Methyldopa reaction simulating septic shock. Archives of Internal Medicine 139: 196–197 (1979).

    PubMed  CAS  Google Scholar 

  • Deumer, H.M.: Adverse effects of beta adrenergic receptor blocking drugs on respiratory function. Drugs 7: 130 (1974).

    Google Scholar 

  • Devine, B.L.; Fife, R. and Trust, P.M.: Minoxidil for severe hypertension after failure of other hypertensive drugs. British Medical Journal 2: 667–669 (1977).

    PubMed  CAS  Google Scholar 

  • Dollery, CT.; Bulpitt, C.J.; Daniel, J. and Clifton, P.: Eye symptoms in patients taking propranolol and other hypotensive agents. British Journal of Clinical Pharmacology 4: 295–297 (1977).

    PubMed  CAS  Google Scholar 

  • Drayer, J.I.M.; Keim, J.H.; Weber, M.A.; Case, D.B. and Laragh, J.H.: Unexpected pressor response to propranolol in essential hypertension: An interaction between renin-aldosterone and sympathetic activity. American Journal of Medicine 60: 897–903 (1976).

    PubMed  CAS  Google Scholar 

  • Drug Commentary Department: Drug evaluation of diazoxide. Journal of the American Medical Association 224: 1422 (1973).

    Google Scholar 

  • Editorial: Captopril. Lancet 2: 129–140 (1980).

    Google Scholar 

  • Enoch, M.D. and Hammad, G.E.M.: Acute hallucinosis due to clonidine. Current Medical Research and Opinion 4: 670–671 (1977).

    PubMed  CAS  Google Scholar 

  • Ferris, J.A.J. and Rice, G.: Drug-induced myocarditis: A report of two cases. Forensic Science International 13: 261–265 (1979).

    PubMed  CAS  Google Scholar 

  • Fleminger, R.: Visual hallucinations and illusions with propranolol. British Medical Journal 1: 1182 (1978).

    PubMed  CAS  Google Scholar 

  • Forfar, J.C; Brown, J.G. and Cull, R.E.: Proximal myopathy during beta-blockade. British Medical Journal 2: 1331–1332 (1979).

    PubMed  CAS  Google Scholar 

  • Formgrew, H.: The effect of metoprolol and practolol on lung function and blood pressure in hypertensive asthmatics. British Journal of Clinical Pharmacology 3: 1007 (1976).

    Google Scholar 

  • Freis, E.D.∷ Salt, volume and the prevention of hypertension. Circulation 53: 589–595 (1976).

    PubMed  CAS  Google Scholar 

  • Frohlich, E.D.: Methyldopa. Mechanisms and treatment 25 years later. Archives of Internal Medicine 140: 954–959 (1980).

    PubMed  CAS  Google Scholar 

  • Gaddie, J. and Skinner, L.: Risk with beta blockers in bronchial asthma. British Medical Journal 1: 749 (1972).

    PubMed  CAS  Google Scholar 

  • Gallery, E.D.M.; Saunders, D.M.; Hunyor, S.N. and Gyory, A.Z.: Randomized comparison of methyldopa and oxprenolol for the treatment of hypertension in pregnancy. British Medical Journal 1: 1591–1594 (1979).

    PubMed  CAS  Google Scholar 

  • Garbus, S.B.; Weber, M.A.; Priest, R.T.; Brewer, D.D. and Hubbell, F.A.: The abrupt discontinuation of antihypertensive treatment. Journal of Clinical Pharmacology 19: 476 (1979).

    PubMed  CAS  Google Scholar 

  • Gifford, R.W., Jr: Hypertensive emergencies and their treatment. Medical Clinics of North America 45: 44(1961).

    Google Scholar 

  • Gifford, R.W.; Jr: Bethanidine sulfate: A new antihypertensive agent. Journal of the American Medical Association 193: 901 (1965).

    PubMed  CAS  Google Scholar 

  • Gilmore, E.; Weil, J. and Chidsey, C.J.: Treatment of essential hypertension with a new vasodilator in combination with beta adrenergic blockade. New England Journal of Medicine 282: 521–527 (1970).

    PubMed  CAS  Google Scholar 

  • Gladstone, G.R.; Hordof, A. and Gersony, W.M.: Propranolol administration during pregnancy: Effects on the fetus. Journal of Pediatrics 86: 962–964 (1975).

    PubMed  CAS  Google Scholar 

  • Goldberg, A.D.; Raftery, E.B. and Wilkinson, P.: Blood pressure and heart rate and withdrawal of antihypertensive drugs. British Medical Journal 1: 243 (1977).

    Google Scholar 

  • Goldberg, R.S. and Thornton, W.E.: Combined tricyclic-MAOI therapy for refractory depression. A review with guidelines for appropriate usage. Journal of Clinical Pharmacology 18: 143–147 (1978).

    PubMed  CAS  Google Scholar 

  • Gomis, G.M.: Intrahepatic cholestasis due to alpha methyldopa. A case report. Boletin de la Asociacion Medica de Puerto Rico 65: 212 (1973).

    Google Scholar 

  • Goodewin, K.F. and Bunney, W., Jr: Depression following reserpine in the evaluation centers. Psychiatry 3: 435 (1971).

    Google Scholar 

  • Graham, R.M. and Pettinger, W.A.: Prazosin. New England Journal of Medicine 300: 232–236 (1979).

    PubMed  CAS  Google Scholar 

  • Graham, R.M.; Thornell, I.R.; Gain, J.M.; Bagnoli, C; Oates, H.F. and Stokes, G.S.: Prazosin: The first-dose phenomenon. British Medical Journal 2: 1293–1294 (1976).

    PubMed  CAS  Google Scholar 

  • Graham, R.M.; Oates, H.F.; Stoker, L.M. and Stokes, G.S.: Alpha-blocking action of the antihypertensive agent, prazosin. Journal of Pharmacology and Experimental Therapeutics 201: 747–752 (1977).

    PubMed  CAS  Google Scholar 

  • Greenblatt, D.J. and Koch-Weser, J.: Adverse reactions to propranolol in hospitalized medical patients: A report from the Boston Collaborative Drug Surveillance Program. American Heart Journal 86: 478–484 (1973).

    PubMed  CAS  Google Scholar 

  • Grieco, M.H. and Pierson, R.N.: Mechanism of bronchoconstriction due to beta adrenergic blockade. Studies with practolol, propranolol, and atropine. Journal of Allergy and Clinical Immunology 48: 143–152 (1971).

    PubMed  CAS  Google Scholar 

  • Guazzi, M.D.; Fiorentini, C; Olivari, M.T.; Bartorelli, A.; Necchi, G. and Polese, A.: Short- and long-term efficacy of a calcium-antagonistic agent (nifedipine) combined with methyldopa in severe hypertension. Circulation 61: 913–919 (1980).

    PubMed  CAS  Google Scholar 

  • Habib, A. and McCarthy, J.S.: Effects on the neonate of propranolol administered during pregnancy. Journal of Pediatrics 91: 808–811 (1977).

    PubMed  CAS  Google Scholar 

  • Harth, M.: LE cells and positive direct Coomb’s test induced by methyldopa. Canadian Medical Association Journal 99: 277 (1968).

    PubMed  CAS  Google Scholar 

  • Harty, R.F.: Sclerosing peritonitis and propranolol. Archives of Internal Medicine 138: 1424–1426(1978).

    PubMed  CAS  Google Scholar 

  • Heel, R.C.; Brogden, R.N.; Speight, T.M. and Avery, G.S.: Captopril: A preliminary review of its pharmacological properties and therapeutic efficacy. Drugs 20: 409–452 (1980).

    PubMed  CAS  Google Scholar 

  • Hesse, B. and Pedersen, J.T.: Hypoglycaemia after propranolol in children. Acta Medica Scandinavica 193: 551–552 (1973).

    PubMed  CAS  Google Scholar 

  • Hoffman, G.C. et al.: Positive Coombs’ test in patients receiving alpha methyldopa. Scientific Abstracts of the American Society of Clinical Pathology and Collection of the American Pathology Meeting September 1967, p.90 (1967).

  • Hoorntje, S.J.; Weening, J.J.; The, T.H.; Kallenberg, C.G.M.; Donker, A.J.M. and Hoedemaeker, P.G.: Immune-complex glomerulonephritis in patients treated with captopril. Lancet 1: 1212–1214 (1980).

    PubMed  CAS  Google Scholar 

  • Hoyumpa, A.M., Jr and Connell, E.M.: Methyldopa hepatitis. American Journal of Digestive Diseases 18: 213 (1973).

    PubMed  Google Scholar 

  • Hua, A.S.P.; Thomas, G.W. and Kincaid-Smith, P.: Scalp tingling in patients on labetalol. Lancet 2: 295 (1977).

    PubMed  CAS  Google Scholar 

  • Hulter, H.N.; Licht, J.H.; Ilnicki, L.P. and Singh, S.: Clinical efficacy in pharmacokinetics of clonidine in hemodialysis and renal insufficiency. Journal of Laboratory and Clinical Medicine 94: 223–231 (1979).

    PubMed  CAS  Google Scholar 

  • Husserl, F.E.; deCarvalho, J.G.R.; Batson, H.M. and Fröhlich, E.D.: Hypertension after clonidine withdrawal. Southern Medical Journal 71: 496–497 (1978).

    PubMed  CAS  Google Scholar 

  • Jane, A.K.; Ryan, J.R. and McMahon, F.G.: A comparative study of the effectiveness of various dose regimens of clonidine (abstr.). Clinical Pharmacology and Therapeutics 19: 109 (1976).

    Google Scholar 

  • Jariwalla, A.J. and Anderson, E.G.: Side effects of drugs. Production of ischaemic cardiac pain by nifedipine. British Medical Journal 1: 1181 (1978).

    PubMed  CAS  Google Scholar 

  • Johnson, P.; Kitchin, A.; Lowther, C.P. and Turner, R.W.D.. Treatment of hypertension with methyldopa. British Medical Journal 1: 133–137 (1966).

    PubMed  CAS  Google Scholar 

  • Katila, M. and Frick, M.H.: Combined dihydralazine and propranolol in the treatment of hypertension. International Journal of Clinical Pharmacology, Therapy, and Toxicology 4: 111–114 (1970).

    PubMed  CAS  Google Scholar 

  • Keim, H.J.; Drayer, J.I.; Case, D.B.; Lopez-Ovejero, J.; Wallace, J.M.; Weber, M.A. and Laragh, J.H.: The role for renin in rebound hypertension and encephalopathy after infusion of saralasin acetate (Sarl-Ala8-angiotensin II). New England Journal of Medicine 295: 1175–1177 (1976).

    PubMed  CAS  Google Scholar 

  • Khatri, I.M. and Cohn, J.N.: Mechanism of exercise hypotension after sympathetic blockade. American Journal of Cardiology 25: 329–338 (1970).

    PubMed  CAS  Google Scholar 

  • Kibler, L.E. and Gazes, P.: The effect of clonidine on atrioventricular conduction. Journal of the American Medical Association 238: 1930–1932 (1977).

    PubMed  CAS  Google Scholar 

  • Kiedan, H.: Impotence during antihypertensive treatment (corresp.). Canadian Medical Association Journal 114: 874 (1976).

    Google Scholar 

  • Kirsmer, J.B. and Ford, H.: The effects of reserpine upon the gastric secretions in man. Archives of Internal Medicine 99: 399 (1957).

    Google Scholar 

  • Koch-Weser, J.: Vasodilator drugs in treatment of hypertension. Archives of Internal Medicine 133: 1017–1027 (1974).

    PubMed  CAS  Google Scholar 

  • Koch-Weser, J.: Diazoxide. New England Journal of Medicine 294: 1271–1273 (1976a).

    PubMed  CAS  Google Scholar 

  • Koch-Weser, J.: Hydralazine. New England Journal of Medicine 295: 320–323 (1976b).

    PubMed  CAS  Google Scholar 

  • Kotier, M.N.; Berman, L. and Rubenstein, A.H.: Hypoglycaemia precipitated by propranolol. Lancet 2: 1389–1390 (1966).

    Google Scholar 

  • Kumar, J.; Dastoor, F.C.; Robayo, J.R. and Razzaque, M.A.: Side effects of diazoxide. Journal of the American Medical Association 235: 275–276 (1967).

    Google Scholar 

  • Landesman, R.; Coutinho, E.M.; Wilson, K.H. and Lopes, A.C. V.: The relaxant effect of diazoxide on non gravita human myometrium in vivo. American Journal of Obstetrics and Gynecology 102: 1080 (1968).

    PubMed  CAS  Google Scholar 

  • Lavin, P. and Alexander, C.P.: Dementia associated with clonidine therapy. British Medical Journal 1: 628 (1975).

    PubMed  CAS  Google Scholar 

  • Law, M.R.; Copland, R.F.P.; Armitstad, J.G. and Gabriel, R.: Labetalol and priapism. British Medical Journal 1: 115 (1980).

    Google Scholar 

  • Lee, P.A.; Kelly, M.R. and Wallin, J.D.: Increased prrolactin levels in reserpine treatment of hypertensive patients. Journal of the American Medical Association 235: 2316–2317 (1976).

    PubMed  CAS  Google Scholar 

  • Lieberman, D.A.; Stirrat, A.M.; Cohen, S.L.; Beard, R.W. and Pinker, G.D.: The possible adverse effects of propranolol on the fetus in pregnancy complicated by severe hypertension. British Journal of Obstetrics and Gynaecology 85: 678–683 (1978).

    PubMed  CAS  Google Scholar 

  • Limis, C.J. and Freis, E.D.: Minoxidil in severe hypertension with renal failure. Effects of its addition to conventional antihypertensive drugs. American Journal of Cardiology 31: 355–361 (1973).

    Google Scholar 

  • Lloyd-Mostyn, R.H. and Oram, S.: Modification by propranolol of cardiovascular effects induced by hypoglycaemia. Lancet 1: 1213–1215 (1975).

    PubMed  CAS  Google Scholar 

  • Luft, F.C.; Broch, R.; Szwed, J.J.; Grim, CM. and Grim, C.E.: Minoxidil treatment of malignant hypertension. Recovery of renal function. Journal of the American Medical Association 240: 1985–1987 (1978).

    PubMed  CAS  Google Scholar 

  • Luria, M.H.; Adelson, E.I. and Miller, A.J.: Acute and chronic effects of an adrenergic beta-receptor blocking agent (propranolol) in treatment of cardiac arrhythmias. Circulation 34: 767–773 (1966).

    PubMed  CAS  Google Scholar 

  • Mack, T.M.; Henderson, B.E.; Gerkins, V.R.; Arthur, M.; Baptista, J. and Pike, M.C.: Reserpine and breast cancer in a retirement community. New England Journal of Medicine 292: 1366–1371 (1975).

    PubMed  CAS  Google Scholar 

  • Maddrey, W.C. and Boitnott, J.D.: Hepatitis — induced by isoniazid and methyldopa. Hospital Practice 10: 119–125 (1975).

    Google Scholar 

  • Mani, M.K.: Nitroprusside revisited. British Medical Journal 3: 407 (1971).

    PubMed  CAS  Google Scholar 

  • Marquez, J.A. and Ulda, P.R.: Pericardial effusion associated with minoxidil (corresp.). Lancet 2: 816 (1977).

    Google Scholar 

  • McMahon, G.: Management of Essential Hypertension, p.194 (Futura, Mt Kisco, NY 1978).

    Google Scholar 

  • McMahon, G.: Management of Essential Hypertension, pp.195–196 (Futura, Mt Kisco, NY 1978).

  • McMahon, G.: Management of Essential Hypertension, pp.355–359 (Futura, Mt Kisco, NY 1978).

    Google Scholar 

  • McMahon, G.: Management of Essential Hypertension, pp.399–400 (Futura, Mt Kisco, NY 1978).

    Google Scholar 

  • McMahon, G.: Management of Essential Hypertension, p.421 (Futura, Mt Kisco, NY 1978).

    Google Scholar 

  • McMahon, F.C.; Cole, P.A. and Boyles, P.W.: Study of a new antihypertensive (guanabenz). Current Therapeutic Research 16: 389–397 (1974).

    PubMed  CAS  Google Scholar 

  • McMahon, G.D.; Schaffer, R.; Huskins, H.D. and Hetherington, J.: Adverse effects experienced by patients taking timolol. American Journal of Ophthalmology 88: 736–738 (1979).

    PubMed  CAS  Google Scholar 

  • McNeil, J.J.; Anderson, A.; Christophidis, N.; Jarrott, B. and Louis, W.J.: The taste loss associated with oral captopril treatment. British Medical Journal 2: 1555–1556 (1979).

    PubMed  CAS  Google Scholar 

  • Marshall, A.J.; McGraw, M.E. and Barritt, D.W.: Positive anti-nuclear factor tests with prazosin. British Medical Journal 1: 165–166 (1979).

    PubMed  CAS  Google Scholar 

  • Martin, CM.; Southwick, E.G. and Maibach, H.I.: Propranolol induced alopecia. American Heart Journal 86: 236 (1973).

    PubMed  CAS  Google Scholar 

  • Medical Letter: Adverse effect of methyldopa. Drug Therapy 10: 22 (1968).

    Google Scholar 

  • Messerli, F.H. and Frohlich, E.D.: High blood pressure. A side effect of drugs, poisons, and food. Archives of Internal Medicine 139: 682–687 (1979).

    PubMed  CAS  Google Scholar 

  • Messerli, F.H.; deCarvalho, J.G.R.; Christie, B. and Frohlich, E.D.: Systemic haemodynamic effects of biofeedback in borderline hypertension. Clinical Science 58: 437–439 (1980).

    Google Scholar 

  • Miller, R.R.; Olson, H.G.; Amsterdam, E.A. and Mason, D.T.: Propranolol withdrawal rebound phenomenon. Exacerbation of coronary events after abrupt cessation of antianginal therapy. New England Journal of Medicine 293: 416–418 (1975).

    PubMed  CAS  Google Scholar 

  • Morgan, T.O.; Sabto, J.; Anavekar, S.N.; Louis, W.J. and Doyle, A.E.: A comparison of beta adrenergic blocking drugs in the treatment of hypertension. Postgraduate Medical Journal 50: 253–259 (1974).

    Google Scholar 

  • Mortensen, K.: Acute myocardial infarction as a possible consequence of abrupt withdrawal of verapamil. Ugeskrift für Laeger 141: 2905 (1979).

    Google Scholar 

  • Mroczek, W.J.; Leibel, B.A. and Finnerty, F.A., Jr: Comparison of clonidine and methyldopa in hypertensive patients receiving a diuretic. A double-blind, cross-over study. American Journal of Cardiology 29: 712–717 (1972).

    PubMed  CAS  Google Scholar 

  • Mueller, J.C.; Rast, C; Pryor, W. and Orgain, E.S.. Late systemic complications of hydralazine therapy. Journal of the American Medical Association 154: 894 (1955).

    Google Scholar 

  • Mullick, F.G. and McAllister, H.A.: Myocarditis associated with methyldopa therapy. Journal of the American Medical Association 237: 1699–1701 (1977).

    PubMed  CAS  Google Scholar 

  • Myers, J.; Morgan, T.; Waga, S.; Hodgson, M. and Adam, W.: Longterm experience with labetolol. Medical Journal of Australia 1: 665–666 (1980).

    PubMed  CAS  Google Scholar 

  • Nawabi, I.U. and Ritz, M.D.: Agranulocytosis due to propranolol. Journal of the American Medical Association 223: 1376–1377 (1973).

    PubMed  CAS  Google Scholar 

  • Nawar, T.; Nolin, L.; Plante, G.E.; Caron, C. and Montambault, P.: Longterm treatment of severe hypertension with minoxidil. Canadian Medical Association Journal 117: 1178–1182 (1977).

    PubMed  CAS  Google Scholar 

  • Nies, A.S.: Adverse reaction and reactions limiting the use of anti-hypertensive drugs. American Journal of Medicine 58: 495–503 (1975).

    PubMed  CAS  Google Scholar 

  • Nies, A.S. and Shand, D.G.: Hypertensive response to propranolol in a patient treated with methyldopa — a proposed mechanism. Clinical Pharmacology and Therapeutics 14: 823 (1973).

    PubMed  CAS  Google Scholar 

  • Nourok, D.S.; Glassock, R.J.; Soloman, D.H. and Maxwell, M.H.: Hypothyroidism following prolonged sodium nitroprusside therapy. American Journal of the Medical Sciences 248: 129–138 (1964).

    PubMed  CAS  Google Scholar 

  • O’Brien, K.P.; Grigor, R.R. and Taylor, P.M.: Intravenous diazoxide in the treatment of hypertension associated with myocardial infarction. British Medical Journal 4: 74–77 (1975).

    PubMed  Google Scholar 

  • Olson, R.J.; Bromberg, B.B. and Zimmerman, T.J.: Apneic spells associated with timolol therapy in a neonate. American Journal of Ophthalmology 88: 120–122 (1979).

    PubMed  CAS  Google Scholar 

  • Osborne, D.R.: Propranolol in Peyronie’s disease. Lancet 1: 1111 (1977).

    PubMed  CAS  Google Scholar 

  • Padfield, P.L.; Beevers, D.G.; Cochran, R.E.L. and McQueen, A.: Skin reactions to beta blockers. British Medical Journal 1: 626 (1975).

    Google Scholar 

  • Padosky, S. and Pattawina, CG.: Hyperosmolar nonketotic diabetic coma. A complication of propranolol therapy. Metabolism 22: 685 (1973).

    Google Scholar 

  • Page, L.B.; Yager, H.M. and Sidd, J.J.: Drugs in the management of hypertension. American Heart Journal 91: 810–815 (1976).

    PubMed  CAS  Google Scholar 

  • Parfrey, P.S.; Clement, M.; Vandenburg, M.J. and Wright, P.: Captopril-induced pemphigus. British Medical Journal 2: 194 (1980).

    Google Scholar 

  • Pederson, O.L.: Comparison of metoprolol and hydrochlorothiazide as antihypertensive agents. European Journal of Pharmacology 10: 381 (1976).

    Google Scholar 

  • Pennisi, A.J.; Takahasi, M.; Bernstein, B.H.; Singsen, B.H.; Uttenbogaart, C.; Ettenger, R.B.; Makekzadeh, M.H.; Hanson, V. and Fine, R.N.: Minoxidil therapy in children with severe hypertension. Journal of Pediatrics 90: 813–819 (1977).

    PubMed  CAS  Google Scholar 

  • Perry, H.M., Jr; Tan, E.M.; Carmody, S. and Sakamoto, A.: Relationship of acetyl transferase activity to antinuclear antibodies and toxic symptoms in hypertensive patients treated with hydralazine. Journal of Laboratory and Clinical Medicine 76: 114–125 (1970).

    PubMed  Google Scholar 

  • Perry, H.M., Jr: Late toxicity of hydralazine resembling systemic lupus erythematosus or rheumatoid arthritis. American Journal of Medicine 54: 58–72 (1973).

    PubMed  Google Scholar 

  • Pettinger, W.A. and Mitchell, H.C.: Minoxidil an alternative to nephrectomy for refractory hypertension. New England Journal of Medicine 289: 167–171 (1973).

    PubMed  CAS  Google Scholar 

  • Pimstone, B.; Joffe, B.; Pimstone, N.; Bonnici, F. and Jackson, W.P.U.: Clinical response to long-term propranolol therapy in hyperthyroidism. South African Medical Journal 43: 1203–1205 (1969).

    PubMed  CAS  Google Scholar 

  • Pitts, N.E.: The clinical evaluation of prazosin hydrochloride a new antihypertensive agent; in Cotton (Ed.) Prazosin — Evaluation of a new antihypertensive agent. Proceedings of a Symposium held at the Centre Interprofessional, Geneva, pp. 149–163 (Excerpta Medica, Amsterdam 1974).

    Google Scholar 

  • Pohl, J.E.F.: Development and management of extrapyramidal symptoms in hypertensive patients treated with diazoxide. American Heart Journal 89: 401 (1975).

    PubMed  CAS  Google Scholar 

  • Prichard, B.N.C. and Ross, E.J.: Use of propranolol in conjunction with alpha receptor blocking drugs in pheochromocytoma. American Journal of Cardiology 18: 394–398 (1966).

    PubMed  CAS  Google Scholar 

  • Proctor, J.D.; Evans, E.F. and Wasserman, A.J.: Comparison of bethanidine dosing schedules for rapid control of blood pressure. Current Therapeutic Research 20: 257–265 (1976).

    PubMed  CAS  Google Scholar 

  • Pryor, J.P. and Khan, O.: Beta blockers and Peyronie’s disease. Lancet 1: 331 (1979).

    PubMed  CAS  Google Scholar 

  • Rackensperger, W.; Gaupp, R.; Mattke, D.J.; et al.: Treatment of acute schizophrenic psychosis with beta adrenergic blocking agents. Arch. Psych. Nervenkrank. 219: 29–36 (1974).

    CAS  Google Scholar 

  • Rafferty, F.B. and Denman, A.N.: Systemic lupus erythematosus-syndrome induced by practolol. Brit. Med. J. 2: 452 (1973).

    Google Scholar 

  • Ram, C.V.S.; Holland, OB., Fairchild, C. and Gomez-Sanchez, C.E.: Withdrawal syndrome following cessation of guanabenz therapy. J. Clin. Pharmacol. 19: 148–150 (1979).

    PubMed  CAS  Google Scholar 

  • Raskin, N.H. and Fishman, R.A.: Pyridoxine deficiency neuropathy to hydralazine. New Engl. J. Med. 273: 1182 (1965).

    PubMed  CAS  Google Scholar 

  • Rauscher, A.; Hurst, J.M. and Collins, G.M.: Nitroprusside toxicity in a renal transplant patient. Anesthesiology 49: 428–430 (1978).

    PubMed  CAS  Google Scholar 

  • Reisin, E.; Abel, R.; Modan, M.; Silverberg, D.S.; Eliahan, H.E. and Modan, B.: Effect of weight loss without salt restriction in the reduction of blood pressure. New England Journal of Medicine 298: 1–6(1978).

    PubMed  CAS  Google Scholar 

  • Richardson, D.W. et al.: Circulatory effects of guanethidine. Circulation 22: 184–190(1960).

    CAS  Google Scholar 

  • Riddiough, M.A.: Preventing, detecting and managing adverse reactions of antihypertensive agents in the ambulant patient with essential hypertension. American Journal of Hospital Pharmacy 34: 465–479 (1977).

    PubMed  CAS  Google Scholar 

  • Robson, R.H.: Recurrent migraine after propranolol. British Medical Journal 39: 1157–1158(1977).

    CAS  Google Scholar 

  • Roger, C. and Stewart, A.: Side effects of nifedipine. British Medical Journal 1: 1619–1620(1978).

    Google Scholar 

  • Romanger, J.M.; Gutierrez, J.G.; Curtis, D. and Chey, W.Y.: Methyldopa induced pancreatitis. American Journal of Digestive Diseases 23: 756–758 (1978).

    Google Scholar 

  • Rosenthal, T.; Teicher, A.; Swartz, K. and Boichis, H.: Minoxidil induced bullous eruption. Archives of Internal Medicine 130: 1156–1157 (1978).

    Google Scholar 

  • Rosing, D.R.; Kent, K.M.; Maron, B.J. and Epstein, S.E.: Response of the systemic and pulmonary circulation to alpha-and beta-blockade (labetalol) at rest and during exercise in hypertensive patients. Circulation 60: 1208–1214 (1979).

    PubMed  CAS  Google Scholar 

  • Safarne, Y.A.: Short-term haemodynamic studies with prazosin; in Cutter (Ed.) Prazosin Evaluation of a New Antihypertensive Agent, pp.64–70 (Excerpta Medica, Amsterdam 1974).

    Google Scholar 

  • Shand, D.: Drug therapy: Propranolol. New England Journal of Medicine 293: 280–285 (1975).

    PubMed  CAS  Google Scholar 

  • Shapiro, A.P.; Schwarts, G.E.; Ferguson, D.C.E.; Redmond, D.P. and Weiss, S.M.: Behavioral methods in the treatment of hypertension. A review of their clinical status. Annals of Internal Medicine 86: 626–636 (1977).

    Google Scholar 

  • Shenkman, L; Podrid, P. and Lowenstein, J.: Hyperthyroidism after propranolol withdrawal. Journal of the American Medical Association 238: 237–239 (1977).

    PubMed  CAS  Google Scholar 

  • Shneerson, J.M. and Gazzard, B.G.: Reversible malabsorption caused by methyldopa. Brit. Med. J. 3: 1456–1457 (1977).

    Google Scholar 

  • Simpson, F.O.: Hypertension and depression and their treatment (editorial). Aust. N.Z. J. Psych. 7: 133–137 (1973).

    CAS  Google Scholar 

  • Skinner, C; Gaddie, J. and Palmer, K.N.: Comparison of effects of metoprolol and propranolol on asthmatic airway obstruction. British Medical Journal 1: 504 (1976).

    PubMed  CAS  Google Scholar 

  • Sondergaard, J.; Wadskov, S. and Jensen, H.A.: Aggravation of psoriasis and the occurrence of psoriaziform cutaneous eruptions induced by practolol. Acta Dermatovenerologica 56: 239 (1976).

    CAS  Google Scholar 

  • Stokes, G.S. and Oates, H.F.: Prazosin: New alpha-adrenergic blocking agent in treatment of hypertension. Cardiovascular Medicine 3: 41–45, 49, 55–57 (1978).

    CAS  Google Scholar 

  • Stokes, G.S.; Gain, J.M.; Mahony, J.F.-, Raftos, J. and Stewart, J.H.: Longterm use of prazosin in combination or alone for treating hypertension. Medical Journal of Australia 2 (Suppl.) 13–16 (1977).

    PubMed  CAS  Google Scholar 

  • Strauss, F.G.; Franklin, S.S.; Lewin, A.J. and Maxwell, M.H.: Withdrawal of antihypertensive therapy. Hypertensive crisis in renovascular hypertension. Journal of the American Medical Association 238: 1734–1736 (1979).

    Google Scholar 

  • Thien, T.H.; Delaere, K.P.J.; Debruyne, F.M.J. and Koene, R.A.P.: Urinary incontinence caused by prazosin. British Medical Journal 1: 622–623 (1978).

    PubMed  CAS  Google Scholar 

  • Thorpe, P.: Pindolol in hypertension. Medical Journal of Australia 1: 1242(1971).

    PubMed  CAS  Google Scholar 

  • Vaidya, R.A.; Vaidya, A.B.; Van Woert, M.H. and Kase, M.G.: Galectorrhea and Parkinson-like syndromes an adverse effect of methyldopa. Metabolism 19: 1068 (1970).

    PubMed  CAS  Google Scholar 

  • Vinik, A.L.; Pimstone, B.L. and Hoffenberg, R.: Sympathetic nervous system blocking in hypothyroidism. Journal of Clinical Endocrinology 28: 725–727 (1968).

    CAS  Google Scholar 

  • Vlachakis, N.B.; Mendlowitz, M. and DeGuzman, D. DeG.: Treatment of essential hypertension with trimazosin, a new vasodilator agent. Current Therapeutic Research 17: 564–569 (1975).

    PubMed  CAS  Google Scholar 

  • Voltolina, A.G.; Thompson, S.E. and Tissue, J.: Acute organic syndrome with propranolol. Clin. Toxicol. 4: 357–359 (1971).

    PubMed  CAS  Google Scholar 

  • von Etta, L. and Burchell, H.: Bradycardia with clonidine. Journal of the American Medical Association 240: 2047 (1978).

    PubMed  Google Scholar 

  • Waal-Manning, H.J.: Hypotensive action of propranolol. Clinical Pharmacology and Therapeutics 7: 588–598 (1966).

    Google Scholar 

  • Wallace, J.M. and Gill, D.P.L.: Prazosin in the diagnosis and treatment of pheochromocytoma. Journal of the American Medical Association 240: 2752–2753 (1978).

    PubMed  CAS  Google Scholar 

  • Weisenberger, D.: Immunoblastic lymph adenopathy associated with methyldopa therapy. Cancer 42: 2322–2327 (1978).

    Google Scholar 

  • Whitsett, L; Chrysant, S.G., Dillard, B.L. and Anton, A.H.: Abrupt cessation of clonidine administration: A prospective study. American Journal of Cardiology 41: 1285 (1978).

    PubMed  CAS  Google Scholar 

  • Wilburn, R.L.; Blaufus, S.A. and Bennett, CM.: Longterm treatment of severe hypertension with minoxin, propranolol, furosemide. Circulation 152: 706–713 (1975).

    Google Scholar 

  • Wilkin, J.K.; Hammond, J.J. and Kirkendall, W.M.: The captopril-induced eruption. A possible mechanism: Cutaneous kinen potentiation. Archives of Dermatology 116: 902 (1980).

    PubMed  CAS  Google Scholar 

  • Wilson, J.D.; Bullock, J.Y.; Sutherland, DC; Main, C. and O’Brien, K.P.: Antinuclear antibodies in patients receiving non-practolol beta-blockers. Brit Med. J. 1: 14–16 (1978).

    PubMed  CAS  Google Scholar 

  • Wright, P.: Untoward effects associated with practolol administration, ocular mucocutaneous syndrome. British Medical Journal 1: 595(1975).

    PubMed  CAS  Google Scholar 

  • Zacest, R.; Gilmore, E. and Koch-Weser, J.. Treatment of essential hypertension with combined vasodilation and beta-adrenergic blockade. New England Journal of Medicine 286: 617–622 (1972).

    PubMed  CAS  Google Scholar 

  • Zacharias, F.J.: Propranolol in hypertension. A 5-year study. Postgraduate Medical Journal 47(Suppl.): 75–79 (1971).

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Medicine, Section on Hypertension and Renal Disease, Ochsner Medical Institutions, New Orleans, USA

    Fred E. Husserl & Franz H. Messerli

Authors
  1. Fred E. Husserl
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Franz H. Messerli
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Husserl, F.E., Messerli, F.H. Adverse Effects of Antihypertensive Drugs. Drugs 22, 188–210 (1981). https://doi.org/10.2165/00003495-198122030-00002

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00003495-198122030-00002

Keywords

Search

Navigation